TuHURA Biosciences (HURA) Preferred Shares (2014 - 2026)
TuHURA Biosciences (HURA) posted quarterly Preferred Shares of $278530.0 for Q1 2026, little changed year-over-year from $278530.0 in Q1 2025, and little changed quarter-over-quarter from $278530.0 in Q4 2025.
TuHURA Biosciences (HURA) Preferred Shares (2014 - 2026) Analysis & Trends
TuHURA Biosciences' Preferred Shares history runs 13 years deep, the most recent figure standing at $278530.0 for Q1 2026.
- In Q1 2026, Preferred Shares changed 0.0% year-over-year to $278530.0; the TTM figure through Mar 2026 stood at $278530.0 (changed 0.0% YoY), while the FY2025 annual figure was $278530.0, changed 0.0% from the prior year.
- Preferred Shares for Q1 2026 stood at $278530.0, roughly flat from $278530.0 in the prior quarter.
- The five-year high for Preferred Shares was $12.3 million in Q2 2022, with the low at $16913.0 in Q4 2023.
- The 5-year median for Preferred Shares is $279000.0 (2022), against an average of $1.6 million.
- The sharpest annual moves came in 2022 and 2023: Preferred Shares plunged 97.92% in 2022, then jumped 3615.41% in 2023.
- TuHURA Biosciences' Preferred Shares stood at $279000.0 in 2022, then slumped by 93.94% to $16913.0 in 2023, then jumped by 1546.84% to $278530.0 in 2024, then changed by 0.0% to $278530.0 in 2025, then changed by 0.0% to $278530.0 in 2026.
- Business Quant data shows HURA's Preferred Shares at $278530.0 in Q1 2026, $278530.0 in Q4 2025, and $278530.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | 278,530.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 278,530.00 |
| Dec 31, 2025 | 278,530.00 |
| Sep 30, 2025 | 278,530.00 |
| Jun 30, 2025 | 278,530.00 |
| Mar 31, 2025 | 278,530.00 |
| Dec 31, 2024 | 278,530.00 |
| Sep 30, 2024 | 279,000.00 |
| Jun 30, 2024 | 279,000.00 |
| Mar 31, 2024 | 279,000.00 |
| Dec 31, 2023 | 16,913.00 |
| Sep 30, 2023 | 279,000.00 |
| Jun 30, 2023 | 279,000.00 |
| Mar 31, 2023 | 10.37 Mn |
| Dec 31, 2022 | 279,000.00 |
| Sep 30, 2022 | 279,000.00 |
| Jun 30, 2022 | 12.28 Mn |
| Mar 31, 2022 | 279,000.00 |
| Dec 31, 2021 | 12.52 Mn |
| Sep 30, 2021 | 13.40 Mn |
| Jun 30, 2021 | 14.65 Mn |